These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 29843214)
1. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches. Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214 [TBL] [Abstract][Full Text] [Related]
2. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
3. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma. Wang J; Tian Y; Chen H; Li H; Zheng S Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
5. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
6. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618 [TBL] [Abstract][Full Text] [Related]
7. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma. Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549 [TBL] [Abstract][Full Text] [Related]
8. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis. Hu S; Liao Y; Chen L Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542 [TBL] [Abstract][Full Text] [Related]
10. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses. Wan Z; Zhang X; Luo Y; Zhao B Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428 [No Abstract] [Full Text] [Related]
11. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis. Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149 [TBL] [Abstract][Full Text] [Related]
12. Analysis of potential key genes in very early hepatocellular carcinoma. Wu M; Liu Z; Li X; Zhang A; Lin D; Li N World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma. Gao X; Wang X; Zhang S Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252 [TBL] [Abstract][Full Text] [Related]
14. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876 [TBL] [Abstract][Full Text] [Related]
15. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction. Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556 [TBL] [Abstract][Full Text] [Related]
16. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis. Yang WX; Pan YY; You CG Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652 [TBL] [Abstract][Full Text] [Related]
17. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis. Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487 [TBL] [Abstract][Full Text] [Related]
18. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056 [TBL] [Abstract][Full Text] [Related]
19. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma. Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843 [TBL] [Abstract][Full Text] [Related]
20. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis. Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]